Rosetta Stone (NYSE:RST) Lowered to Buy at ValuEngine

Share on StockTwits

Rosetta Stone (NYSE:RST) was downgraded by research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday, ValuEngine reports.

Several other brokerages have also issued reports on RST. Lake Street Capital upped their target price on shares of Rosetta Stone from $21.00 to $26.00 and gave the stock a “buy” rating in a research report on Wednesday, May 8th. Barrington Research reiterated a “buy” rating and issued a $29.00 target price on shares of Rosetta Stone in a research report on Wednesday. Finally, Zacks Investment Research upgraded shares of Rosetta Stone from a “hold” rating to a “buy” rating and set a $29.00 target price for the company in a research report on Tuesday, May 14th. Five investment analysts have rated the stock with a buy rating, Rosetta Stone currently has an average rating of “Buy” and an average price target of $28.50.

RST opened at $18.44 on Thursday. The firm’s fifty day moving average price is $22.78. The stock has a market cap of $485.93 million, a price-to-earnings ratio of -19.41 and a beta of 0.22. Rosetta Stone has a one year low of $14.41 and a one year high of $26.88.

Rosetta Stone (NYSE:RST) last announced its earnings results on Tuesday, August 6th. The software maker reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.15. The company had revenue of $45.94 million during the quarter, compared to analysts’ expectations of $44.50 million. As a group, equities research analysts predict that Rosetta Stone will post -0.6 earnings per share for the current year.

In other Rosetta Stone news, insider Nicholas C. Gaehde sold 2,500 shares of the company’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $26.02, for a total transaction of $65,050.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Thomas M. Pierno sold 111,363 shares of the company’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $23.95, for a total transaction of $2,667,143.85. Following the sale, the chief financial officer now owns 203,067 shares of the company’s stock, valued at $4,863,454.65. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 262,355 shares of company stock valued at $6,561,632. Company insiders own 13.50% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Marshall Wace LLP purchased a new stake in Rosetta Stone during the first quarter valued at about $34,000. Quantamental Technologies LLC purchased a new stake in Rosetta Stone during the first quarter valued at about $46,000. Legal & General Group Plc boosted its position in Rosetta Stone by 34.8% during the fourth quarter. Legal & General Group Plc now owns 3,936 shares of the software maker’s stock valued at $65,000 after buying an additional 1,016 shares during the period. Aperio Group LLC purchased a new stake in Rosetta Stone during the second quarter valued at about $82,000. Finally, BNP Paribas Arbitrage SA boosted its position in Rosetta Stone by 359.1% during the first quarter. BNP Paribas Arbitrage SA now owns 4,132 shares of the software maker’s stock valued at $90,000 after buying an additional 3,232 shares during the period. Institutional investors and hedge funds own 82.22% of the company’s stock.

About Rosetta Stone

Rosetta Stone Inc, together with its subsidiaries, provides technology-based learning products in the United States and internationally. It operates through three segments: Literacy, E&E Language, and Consumer Language. The company develops, markets, and supports a suite of language-learning, literacy, and brain fitness solutions consisting of Web-based software subscriptions, perpetual software products, online and professional services, audio practice products, and mobile applications.

Featured Article: What is a Special Dividend?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Rosetta Stone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Stone and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Citadel Advisors LLC Has $203.79 Million Position in Alliant Energy Co.
Citadel Advisors LLC Has $203.79 Million Position in Alliant Energy Co.
Bristol-Myers Squibb Co  Shares Purchased by New England Asset Management Inc.
Bristol-Myers Squibb Co Shares Purchased by New England Asset Management Inc.
New England Asset Management Inc. Has $25,000 Stake in General Electric
New England Asset Management Inc. Has $25,000 Stake in General Electric
New England Asset Management Inc. Invests $1.35 Million in Newmont Goldcorp Corp
New England Asset Management Inc. Invests $1.35 Million in Newmont Goldcorp Corp
New England Asset Management Inc. Grows Stock Holdings in Walt Disney Co
New England Asset Management Inc. Grows Stock Holdings in Walt Disney Co
New England Asset Management Inc. Has $1.69 Million Stock Position in Elanco Animal Health
New England Asset Management Inc. Has $1.69 Million Stock Position in Elanco Animal Health


© 2006-2019 Ticker Report